Varex Imaging Corp Stock Price, News & Analysis

Varex Imaging Corporation (Nasdaq: VREX), a leading manufacturer of X-ray imaging components, has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its unaudited financial results on Thursday, August 7, 2025, after market close, followed by a conference call at 3:00 PM Mountain Time.

Investors can access the conference call via U.S. toll-free number (877-524-8416) or international number (412-902-1028). The webcast will be available on the company's investor relations website, with a replay accessible through August 21st using access code 13754994.

Varex Imaging (Nasdaq: VREX) has secured new orders worth $17 million for its high-energy non-intrusive cargo and vehicle inspection systems from international customers. The systems will be deployed at strategic sea and land ports for security purposes.

CEO Sunny Sanyal highlighted that the company's Cargo Systems business has received orders totaling over $55 million year-to-date, demonstrating Varex's strong position in high-energy Linear Accelerator based imaging technology and its integration capabilities.

Varex Imaging Corporation (VREX) has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. The company's management team is scheduled to deliver a presentation on Wednesday, June 4, 2025, at 8:10 AM ET. Interested parties can access the webcast through a provided link or via Varex's official website at www.vareximaging.com/news.

Varex Imaging (NASDAQ: VREX) reported its Q2 FY2025 financial results with revenues of $213 million, up 3% year-over-year. The company achieved a GAAP gross margin of 36% and non-GAAP gross margin of 36%. Medical segment revenue reached $154 million (up 3%), while Industrial segment revenue was $59 million (up 3%). Non-GAAP EPS improved to $0.26 from $0.16 in Q2 FY2024. Cash flow from operations was $17 million, with cash and equivalents at $226 million. However, due to high Chinese tariffs on U.S. products causing customers to pause purchases, Varex reduced its Q3 FY2025 outlook, projecting revenues between $180-200 million and non-GAAP EPS between -$0.05 and $0.10. The company plans to repay its Convertible Notes due June 2025 at maturity.

Varex Imaging Corporation (VREX) has secured orders worth $25 million USD for its high-energy non-intrusive cargo and vehicle inspection systems from an international customer. The systems will be deployed at strategic sea and land ports for security purposes. CEO Sunny Sanyal highlighted the company's leadership in high-energy Linear Accelerator based imaging technology, emphasizing how their reputation for quality and excellence has helped secure new business in Cargo Systems.

Varex Imaging (VREX) has announced it will release its unaudited financial results for the second quarter of fiscal year 2025 after market close on Thursday, May 8, 2025. The company will host a conference call at 3:00 pm Mountain Time on the same day.

Investors can participate through multiple channels: via webcast on the company's investor relations website, by calling 877-524-8416 (U.S.) or 412-902-1028 (international). A replay will be available from May 8th through May 22nd.

Varex is a leading manufacturer of X-ray imaging components and systems, with a 70+ year history in innovation. The company produces X-ray tubes, digital detectors, and imaging solutions for both medical and industrial applications, employing approximately 2,300 people across North America, Europe, and Asia.

Varex Imaging (VREX) has announced its upcoming participation in two major investor conferences in March 2025. The company will present at the Oppenheimer's 35th Annual MedTech & Services Virtual Conference on Monday, March 17, 2025, at 12:00 PM ET, followed by the Sidoti Small Cap Virtual Conference on Wednesday, March 19, 2025, at 12:15 PM ET.

Both presentations will be accessible via webcast through the provided links or through Varex's official website at vareximaging.com/news.

Varex Imaging (VREX) reported Q1 FY2025 financial results with revenues of $200 million, representing a 5% year-over-year increase. The Medical segment revenue grew 3% to $145 million, while the Industrial segment saw a 10% increase to $55 million.

The company achieved a GAAP gross margin of 34% and non-GAAP gross margin of 35%, with operating margins of 6% (GAAP) and 7% (non-GAAP). The quarter resulted in a GAAP net loss of $0.01 per diluted share, while non-GAAP earnings were $0.07 per share. Cash flow from operations was $10 million, with cash and equivalents reaching $219 million.

For Q2 FY2025, Varex expects revenues between $200-215 million and non-GAAP earnings per diluted share between $0.05-0.20.

Varex Imaging (VREX) has secured orders worth approximately $14 million USD for its non-intrusive cargo inspection systems. The orders specifically target the company's recently launched high-energy inspection products: the VXP-6 Portal and VXM-6 Mobile systems, designed for cargo and vehicle inspection at ports and borders.

CEO Sunny Sanyal expressed enthusiasm about the market reception of their new full screening systems product line, highlighting how the company's expertise in high-energy linear accelerators enables them to expand their security infrastructure offerings globally.